Volume 25, Issue 11, Pages (November 2017)

Slides:



Advertisements
Similar presentations
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
Advertisements

Figure 1 Body weight of control and BPA-treated mothers after delivery
Volume 39, Issue 5, Pages (November 2013)
Induction of Apoptosis by Crambene Protects Mice against Acute Pancreatitis via Anti- Inflammatory Pathways  Yang Cao, Sharmila Adhikari, Marie Véronique.
The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis  Rana Herro, Ricardo Da S. Antunes, Amelia R. Aguilera,
Serotonin Has a Key Role in Pathogenesis of Experimental Colitis
Volume 143, Issue 5, Pages e7 (November 2012)
Volume 131, Issue 3, Pages (September 2006)
Restoration of Corneal Transparency by Mesenchymal Stem Cells
Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus- Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration.
Aryl Hydrocarbon Receptor Regulates Pancreatic IL-22 Production and Protects Mice From Acute Pancreatitis  Jing Xue, David T.C. Nguyen, Aida Habtezion 
Volume 17, Issue 6, Pages (December 2002)
Targeting Improves MSC Treatment of Inflammatory Bowel Disease
MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
Molecular Therapy - Nucleic Acids
Volume 15, Issue 1, Pages (January 2007)
Volume 18, Issue 5, Pages (May 2010)
Volume 8, Issue 5, Pages (May 2017)
Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy  Che-Hsin Lee, Chao-Liang Wu, Yun-Sheng.
Volume 9, Issue 3, Pages (March 2004)
G.-I. Im, H.-J. Kim  Osteoarthritis and Cartilage 
Tumor Necrosis Factor-α-Activated Human Adipose Tissue–Derived Mesenchymal Stem Cells Accelerate Cutaneous Wound Healing through Paracrine Mechanisms 
Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis  Jung-Yeon Kim, Hyun-Jin An, Woon-Hae.
Volume 88, Issue 3, Pages (September 2015)
Exaggerated inflammatory environment decreases BMP-2/ACS-induced ectopic bone mass in a rat model: implications for clinical use of BMP-2  R.-L. Huang,
Volume 39, Issue 5, Pages (November 2013)
Volume 23, Issue 5, Pages (May 2015)
Volume 18, Issue 10, Pages (October 2010)
Volume 13, Issue 12, Pages (December 2015)
Volume 135, Issue 4, Pages (October 2008)
Volume 25, Issue 6, Pages (June 2017)
Volume 29, Issue 4, Pages (April 2016)
Volume 134, Issue 3, Pages (March 2008)
Oral Administration of Recombinant Adeno-associated Virus-mediated Bone Morphogenetic Protein-7 Suppresses CCl4-induced Hepatic Fibrosis in Mice  Zhi-Ming.
Volume 17, Issue 1, Pages (January 2010)
Volume 134, Issue 2, Pages e3 (February 2008)
Volume 19, Issue 1, Pages (January 2011)
Volume 10, Issue 2, Pages (February 2018)
Molecular Therapy - Nucleic Acids
Docosahexaenoic Acid Alleviates Atopic Dermatitis by Generating Tregs and IL-10/TGF- β-Modified Macrophages via a TGF-β-Dependent Mechanism  Sang-Chul.
Volume 129, Issue 2, Pages (August 2005)
Volume 25, Issue 3, Pages (March 2017)
Volume 131, Issue 6, Pages (December 2006)
Volume 12, Issue 1, Pages (July 2015)
Molecular Therapy - Methods & Clinical Development
Volume 137, Issue 5, Pages (November 2009)
Volume 26, Issue 1, Pages (January 2018)
Volume 17, Issue 1, Pages (January 2010)
Increased Severity of Bleomycin-Induced Skin Fibrosis in Mice with Leukocyte-Specific Protein 1 Deficiency  JianFei Wang, Haiyan Jiao, Tara L. Stewart,
Volume 25, Issue 6, Pages (June 2017)
Volume 25, Issue 7, Pages (July 2017)
Maryam G. Rohani, Ryan S. McMahan, Maria V. Razumova, Angie L
Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node  Lifang Cheng,
Volume 25, Issue 1, Pages (January 2017)
LncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy  Juan Wang, Jian Pang, Huiling Li, Jie Long, Fang Fang, Junxiang Chen,
Volume 25, Issue 3, Pages (March 2017)
Volume 19, Issue 4, Pages (April 2011)
Volume 23, Issue 1, Pages (January 2015)
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Volume 25, Issue 6, Pages (June 2017)
Volume 12, Issue 1, Pages (July 2005)
Volume 24, Issue 1, Pages (January 2016)
Volume 21, Issue 2, Pages (February 2013)
The extra domain A of fibronectin is essential for allergen-induced airway fibrosis and hyperresponsiveness in mice  Martin Kohan, MSc, Andres F. Muro,
Volume 25, Issue 3, Pages (March 2017)
Loss of Transgene following ex vivo Gene Transfer is Associated with a Dominant Th2 Response: Implications for Cutaneous Gene Therapy  Zhenmei Lu, Soosan.
Volume 25, Issue 6, Pages (June 2017)
Volume 23, Issue 12, Pages (June 2018)
Repulsive Guidance Molecule-a Is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis  Shogo Tanabe, Toshihide Yamashita  Cell.
Aminoglycoside Enhances the Delivery of Antisense Morpholino Oligonucleotides In Vitro and in mdx Mice  Mingxing Wang, Bo Wu, Sapana N. Shah, Peijuan.
Presentation transcript:

Volume 25, Issue 11, Pages 2490-2501 (November 2017) Adipose Stem Cell Therapy Mitigates Chronic Pancreatitis via Differentiation into Acinar- like Cells in Mice  Zhen Sun, Wenyu Gou, Do-sung Kim, Xiao Dong, Charlie Strange, Yu Tan, David B. Adams, Hongjun Wang  Molecular Therapy  Volume 25, Issue 11, Pages 2490-2501 (November 2017) DOI: 10.1016/j.ymthe.2017.06.016 Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 1 Ethanol and Cerulean-Induced CP Mouse Model (A) Body weight changes in mice after saline (CTR) or ethanol and cerulein (E+C) injections (n = 10 per group). (B) Food intake in mice treated with saline or ethanol and cerulein 2 weeks after CP induction. (C) Representative H&E staining of pancreatic tissue from mice receiving saline (control) or ethanol and cerulein 1 and 3 weeks after injection. Scale bars, 100 μm. Data presented are mean ± SEM. Differences were compared by one-way ANOVA; *p < 0.05. Molecular Therapy 2017 25, 2490-2501DOI: (10.1016/j.ymthe.2017.06.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 2 Characteristics of CP Mice (A) Micrographs of GFP+ ASCs observed by light or fluorescent microscopy. Scale bars, 100 μm. (B) Schematic diagram of CP induction, cell infusion, and tissue collection and analysis. (C) Images of pancreases collected from normal control, CP control, or CP mice treated with ASCs (4 × 105 or 1 × 106 cells/mouse). (D and E) Pancreas weights (D) and percent ratio of pancreas weight to body weight (E) in control, CP control, or CP mice treated with ASCs (4 × 105 or 1 × 106 cells/mouse). Data presented are mean ± SEM. Differences were compared by one-way ANOVA; *p < 0.05. Molecular Therapy 2017 25, 2490-2501DOI: (10.1016/j.ymthe.2017.06.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 3 Effects of ASC Injection on Pancreas Damage, Fibrosis, and Macrophage Infiltration (A) Histological analysis of pancreas tissue sections from normal control or CP mice treated either with PBS or ASCs at 4 × 105 cells/mouse. H&E staining, Masson-Goldner-trichrome staining, and staining with antibodies against collagen, α-SMA, and F4/80 are shown. Scale bar, 100 μm. (B–D) Percentages of positive area in total pancreatic area of (B) Masson-Goldner, (C) collagen, and (D) α-SMA. Data are means ± SEMs. *p < 0.05 compared with normal control; #p < 0.05 compared with CP-PBS group, one-way ANOVA test. Molecular Therapy 2017 25, 2490-2501DOI: (10.1016/j.ymthe.2017.06.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 4 ASC Infusion Protects against Pancreatic Cell Death (A) Immunostaining of TUNEL+ cells in the pancreas from normal control, CP mice treated with PBS, or ASCs (4 × 105 cells/mouse) 2 weeks after infusion. Scale bars, 100 μm. (B) Average numbers of TUNEL+ cells in pancreas sections. Data presented are mean ± SEM. Differences were compared by one-way ANOVA; *p < 0.05 compared with normal control; #p < 0.05 compared with CP-PBS group. Molecular Therapy 2017 25, 2490-2501DOI: (10.1016/j.ymthe.2017.06.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 5 Differentiation of Infused ASCs into Amylase+ and Insulin+ Cells in the Treated Pancreas (A) Real-time RT-PCR analysis of mRNA expression of GFP in the pancreas, liver, and lungs from normal controls, CP controls, and ASC-treated CP mice 2 weeks after injection. (B) Immunohistochemical staining of pancreatic tissues from mice receiving ASCs (upper panels) or PBS (lower panels) with the anti-GFP and the anti-amylase antibodies. Green represents GFP+ cells, and red identifies amylase+ cells. Nuclei are stained blue (DAPI). Scale bar, 50 μm. Data presented are mean ± SEM. Differences were compared by one-way ANOVA. Molecular Therapy 2017 25, 2490-2501DOI: (10.1016/j.ymthe.2017.06.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 6 ASCs Differentiate into Amylase+ Cells In Vitro When Co-cultured with Acinar Cells or in Acinar Cell-Conditioned Medium (A) ASCs cultured alone (CTR), cultured in AR42J-conditioned medium (A-CM), or co-cultured with AR42J cells (ASCAC) were stained for GFP (green) and amylase (red). AR42J cells were used as a positive control for amylase staining. Nuclei are stained blue (DAPI). Scale bar, 50 μm. (B and C) Relative expression of amylase 1 and chymoB1 (B) and fibronectin and vimentin (C) after 7 or 14 days of culture, in ASCs cultured alone (CTR), in ASCs cultured in low-dose AR42J-conditioned medium (A-CM-L), ASCs cultured in high-dose AR42J-conditioned medium (A-CM-H), or ASCs co-cultured with acinar cells. Data presented are mean ± SEM. Differences were compared by one-way ANOVA; *p < 0.05 versus CTR, #p < 0.05 versus ASCAC. Molecular Therapy 2017 25, 2490-2501DOI: (10.1016/j.ymthe.2017.06.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions

Figure 7 Co-culture with ASC-Conditioned Medium Inhibits Ethanol and Cerulein-Induced Expression of Proinflammatory Cytokines in AR42J Cells and imPSCs (A–F) Expression of TNF-α (A and D), IL-6 (B and E), and fibronectin (C and F) in AR42J cells or imPSCs. Data are representative of at least three individual experiments. Data presented are mean ± SEM. Differences were compared by one-way ANOVA; *p < 0.05. ASC-CM, cells cultured in ASC-conditioned medium; ASC-CM+EC, cells cultured in ASC-conditioned medium challenged with ethanol and cerulein; N-M, cells cultured in DMEM/F12; N-M+EC, cells cultured in DMEM/F12 challenged with ethanol and cerulein. Molecular Therapy 2017 25, 2490-2501DOI: (10.1016/j.ymthe.2017.06.016) Copyright © 2017 The American Society of Gene and Cell Therapy Terms and Conditions